Eli Lilly's obesity drug now available in U.S. pharmacies

Eli Lilly's (LLY.N) recently approved obesity treatment Zepbound is now available in U.S. pharmacies and could cost customers whose health insurance does not cover the drug $550 a month, or half the list price, the company said on Tuesday.